MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
AXGN AxoGen
- 15.640
- +0.790+5.32%
Close Dec 20 16:00 ET
- 16.000
- +0.360+2.30%
Post 20:01 ET
688.29MMarket Cap-47.39P/E (TTM)
15.890High14.540Low1.10MVolume14.660Open14.850Pre Close17.13MTurnover2.84%Turnover RatioLossP/E (Static)44.01MShares15.90052wk High6.92P/B607.49MFloat Cap5.55052wk Low--Dividend TTM38.84MShs Float56.850Historical High--Div YieldTTM9.09%Amplitude0.164Historical Low15.544Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
AxoGen Stock Forum
loading...
looks like more 💰flow and narrower loss this years looks interesting here
In reaction to earnings/guidance:
• $Silvergate Capital (SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $AxoGen (AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $Novartis AG (NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
• $Intercept Pharmaceuticals (ICPT.US)$ +25.7% (to sell license to commercialize Ocaliva outside the US to Advanz Pharma for upfront payment of $405 mln)
• $Albemarle (ALB.US)$ +13.9% (earnings reports)
• $Booking Holdings (BKNG.US)$ +10% (Booking Holdings' Outlook for a 'Busy' summer season drives the stock sharply higher)
• $AxoGen (AXGN.US)$ +9% (reports top-line results from RECON study of Avance Nerge Graft)
• $Cumulus Media (CMLS.US)$ +7.2% (an...
No comment yet